logo-loader
viewFrontier IP Group PLC

Frontier IP's Amprologix secures contract to take its antibiotic into the clinic

Frontier IP Group Plc’s (LON:FIPP) CEO Neil Crabb tells Proactive London's Andrew Scott its portfolio firm, Amprologix, has won a £1.2mln UK government contract to accelerate the development of a new antibiotic to tackle antimicrobial resistant MRSA and other superbugs.

As part of a broader catch up on portfolio developments since the New Year, Crabb discusses The Vaccine Group landing a £403,000 government grant. The cash received is part of a £1.46mln Anglo-Chinese project to combat an emerging antibiotic-resistant disease able to jump from pigs to humans with potentially fatal effect.

Plus he updates on Nandi Proteins which has won a grant to improve the quality of gluten-free bread.

Quick facts: Frontier IP Group PLC

Price: 80.5 GBX

AIM:FIPP
Market: AIM
Market Cap: £40.8 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: Another record year for revenues at Westminster Group

Headlines from the Proactive UK newsroom. Westminster (LON:WSG) says 2019 was another record year for revenues, with the turnover rising 63% year on year to £10.9mln. The security group also expects to report a greatly improved underlying profit performance compared to 2018. Frontier IP...

3 weeks, 3 days ago

2 min read